Much advised Wesana Health in the successful closing of its reverse takeover of Debut Diamonds Inc. and its public company listing on the Canadian Securities Exchange. Wesana Health focuses on the development of psilocybin-based treatments that aim to treat individuals who suffer from traumatic brain injury.
Principals David Brown, Matthew Feery, David Schmidt, and Julia Turk served as advisors to Wesana Health.
In addition to its work in connection with the RTO, the Much team guided Wesana Health as it prepared to be listed on the CSE, which involved, among other things, assistance with the exchange, consolidation, and redesignation of its shares in preparation for the listing. On May 10, the company announced that its shares would commence trading under the ticker symbol "WESA."
In March, Much represented Wesana Health during the successful closing of C$16.1 million in an oversubscribed private placement of subscription receipts through a special purpose financing vehicle ahead of the RTO.